Samuel T. Chao
Expertise in
51
conditions

Dr. Samuel T. Chao

Radiation Oncology
9500 Euclid Ave, 
Cleveland, OH 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
51
conditions
9500 Euclid Ave, 
Cleveland, OH 

Overview

Samuel Chao is a Radiation Oncologist practicing medicine in Cleveland, Ohio.

Dr. Chao is highly rated in 51 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Glioma, Astrocytoma, Glioblastoma, and Gamma Knife Radiosurgery.

Dr. Chao is board certified in American Board Of Radiology, 2007. He is actively involved in clinical research, co-authoring 219 peer reviewed articles and participating in 8 clinical trials. Dr. Chao is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in OH

Board Certifications

American Board Of Radiology, 2007

Hospital Affiliations

Multicare Auburn Medical Center
Cleveland Clinic
Hillcrest Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AultCare
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
CommuniCare Advantage
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Paramount
  • EPO
  • HMO
  • INDEMNITY
  • PPO
Primetime Health Plan
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE PART D
Provider Partners Health Plan
  • MEDICARE SNP
SummaCare
  • HMO
  • PPO
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Univera Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 20 Less Insurance Carriers -

Locations

Cleveland Clinic Main Campus
9500 Euclid Ave, Cleveland, OH 44195
Other Locations
Cleveland Clinic Main Campus
10201 Carnegie Avenue, Cleveland, OH 44106

Additional Areas of Focus

Dr. Chao has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Radiation, Drug
Study Drug: Temozolomide
Study Phase: Phase 2
A Safety Run-In and Phase II Study Evaluating the Efficacy, Safety, and Impact on the Tumor Microenvironment of the Combination of Tocilizumab, Atezolizumab, and Fractionated Stereotactic Radiotherapy in Recurrent Glioblastoma
A Safety Run-In and Phase II Study Evaluating the Efficacy, Safety, and Impact on the Tumor Microenvironment of the Combination of Tocilizumab, Atezolizumab, and Fractionated Stereotactic Radiotherapy in Recurrent Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: August 27, 2026
Intervention Type: Procedure, Biological, Radiation
Study Drugs: Atezolizumab, Tocilizumab
Study Phase: Phase 2
A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases
A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases
Enrollment Status: Completed
Publish Date: June 25, 2026
Intervention Type: Radiation
Study Phase: Phase 1
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Enrollment Status: Active_not_recruiting
Publish Date: January 22, 2026
Intervention Type: Drug, Radiation
Study Drugs: Concomitant Temozolomide (TMZ), Procarbazine, Adjuvant Temozolomide (TMZ), CCNU, Vincristine
Study Phase: Phase 3
Dose Escalation for Larger Brain Metastases: Phase I/II Study
Dose Escalation for Larger Brain Metastases: Phase I/II Study
Enrollment Status: Active_not_recruiting
Publish Date: July 20, 2025
Intervention Type: Procedure, Radiation
Study Phase: Phase 1
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Other, Radiation, Drug
Study Drug: Lapatinib Ditosylate
Study Phase: Phase 2
Phase II Trial Of Optune® Plus Bevacizumab In Bevacizumab-Refractory Recurrent Glioblastoma
Phase II Trial Of Optune® Plus Bevacizumab In Bevacizumab-Refractory Recurrent Glioblastoma
Enrollment Status: Terminated
Publish Date: June 02, 2021
Intervention Type: Device, Drug
Study Phase: Phase 2
A Prospective Pilot to Evaluate the Diagnostic Assessment of 18F-Fluciclovine Positron Emission Tomography to Distinguish Tumor Progression From Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases
A Prospective Pilot to Evaluate the Diagnostic Assessment of 18F-Fluciclovine Positron Emission Tomography to Distinguish Tumor Progression From Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases
Enrollment Status: Completed
Publish Date: May 05, 2021
Intervention Type: Device, Drug
Study Phase: Early Phase 1
View 7 Less Clinical Trials

219 Total Publications

The first respiratory interdisciplinary series seminar was held in Beijing City
The first respiratory interdisciplinary series seminar was held in Beijing City
Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Published: July 27, 2026
Similar Doctors
Expertise in
51
conditions
Dr. John H. Suh
Radiation Oncology
Expertise in
51
conditions
Dr. John H. Suh
Radiation Oncology
Referral may be required

Cleveland Clinic Main Campus

9500 Euclid Avenue, 
Cleveland, OH 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Suh is a Radiation Oncologist practicing medicine in Cleveland, Ohio. Dr. Suh is highly rated in 51 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Glioma, Astrocytoma, Glioblastoma, and Gamma Knife Radiosurgery. Dr. Suh is currently accepting new patients.

Expertise in
13
conditions
Dr. Nathan A. Pennell
Radiation Oncology
Expertise in
13
conditions
Dr. Nathan A. Pennell
Radiation Oncology
Referral may be required

Cleveland Clinic Main Campus

9500 Euclid Avenue, 
Cleveland, OH 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Nathan Pennell is a Radiation Oncologist practicing medicine in Cleveland, Ohio. Dr. Pennell is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Thyroidectomy. Dr. Pennell is currently accepting new patients.

Expertise in
15
conditions
Dr. James P. Stevenson
Radiation Oncology
Expertise in
15
conditions
Dr. James P. Stevenson
Radiation Oncology
Referral may be required

Cleveland Clinic Main Campus

9500 Euclid Avenue, 
Cleveland, OH 
 (0.1 miles away)
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

James Stevenson is a Radiation Oncologist practicing medicine in Cleveland, Ohio. Dr. Stevenson is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC). Dr. Stevenson is currently accepting new patients.

Frequently Asked Questions about Dr. Samuel T. Chao

How do I make an appointment with Dr. Samuel T. Chao?

You can book an appointment with Dr. Samuel T. Chao by calling their office at 866-223-8100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Samuel T. Chao a top-rated expert for Brain Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Samuel T. Chao is classified as an Elite expert for Brain Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Samuel T. Chao specialize in?

While Dr. Samuel T. Chao is a Radiation Oncology, they have specific expertise in Brain Tumor, Gamma Knife Radiosurgery, and Glioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Samuel T. Chao participate in research or clinical trials?

Yes. Dr. Samuel T. Chao has published 219 articles and abstracts on conditions like Brain Tumor. You can view a list of Dr. Samuel T. Chao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Samuel T. Chao accept my insurance?

Dr. Samuel T. Chao accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 866-223-8100 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chao's expertise for a condition
ConditionClose
View All 18 Distinguished Conditions
View All 27 Advanced Conditions
View All 67 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile